SY-004

· Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SY-004, covering 2022-05-18 to 2022-05-18. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus [Phase 2]